Fig. 2From: Topical estrogen, testosterone, and vaginal dilator in the prevention of vaginal stenosis after radiotherapy in women with cervical cancer: a randomized clinical trialVaginal stenosis (CTCAE v3.0 scale) in the different groups during follow-up (n = 142)Back to article page